Search

A single 200-meter long high temperature superconducting (HTS) three-phase triaxial design cable is installed at the American Electric Power (AEP) Bixby substation in Columbus, Ohio. Findings reveal that the cable demonstrate steady state operation, high voltage operation, high voltage withstand and 110 kV impulse and overcurrent fault capability.

The development and testing of high temperature superconducting cables and terminations at the Oak Ridge National Laboratory is described.

Two 3-rn long, single-phase cables have been fabricated by Ultera from second generation (2G) superconductor wire supplied by American Superconductor. The first cable was made with two layers of 2G tape conductor and had a critical current of 5,750 A while the second cable had four layers and a critical current of 8,500 A. AC loss was measured for both cables at ac currents of up to 4 kArms. Ultera performed initial fault current studies of both cables in Denmark with limited currents in the range from 9.1 to 44 kA. Results from these tests will provide a basis for a 25-m long, three-phase, prototype cable to be tested at ORNL early next year and a 300-rn long, fault current limiting, superconducting cable to be installed in a Consolidated Edison substation in New York City. [ABSTRACT FROM AUTHOR]

The use of high temperature superconducting (HTS) materials for power transmission cable applications is being realized in several utility demonstration projects. Tape testing on short-sample cables is conducted to determine the suitability of HTS tapes for use in different cable designs. Testing includes deter- mining the DC critical current, ac loss and overcurrent behavior in a wound cable configuration. The short-sample cable configuration is similar in physical respects, such as winding diameter, winding pitch, application of dielectric, to a practical length cable. With more attention being paid to the short-circuit fault protection, the over-current pulse behavior of the cable will be tested thoroughly. The temperature history of the cable in the radial direction and the re-cooling of the cable will be monitored and compared with a model calculation. This paper describes the testing and results from one such series of tests of a short-sample cable made with copper laminated HTS tapes for use in future projects. [ABSTRACT FROM AUTHOR]

The Ultera/ORNL team have built and tested 3-m and 5-m triaxial cables rated at 3 and 1.3 kA-rms, respectively. The three concentric superconducting phases are made of BSCCO-2223 HTS tapes, separated by layers of cold-dielectric tapes. A copper braid is added as the grounding shield on the outside of the three active phases. Tests of these cables were performed at temperatures ranging from 70 to 84 K. AC loss data reconfirmed the previous result on a 1.5-m prototype cable that the total 3-phase ac loss is about the sum of the calculated ac losses of the three concentric phases. These and other test results of the 1,3 and 3 kA cables will be used to construct a second S-m triaxial cable rated at 3 kA-rms, 15 kV. Preliminary test results supporting this new cable and the associated termination are summarized. [ABSTRACT FROM AUTHOR]

Multiple myeloma is a genetically complex and heterogenous malignancy with a 5-year survival rate of approximately 60%. Despite advances in therapy, patients experience cycles of remission and relapse, with each successive line of therapy associated with poorer outcomes; therefore, therapies with different mechanisms of action against new myeloma antigens are needed. G protein-coupled receptor class C group 5 member D (GPRC5D) has emerged as a novel therapeutic target for the treatment of multiple myeloma. We review the biology and target validation of GPRC5D, and clinical data from early phase trials of GPRC5D-targeting bispecific antibodies, talquetamab and forimtamig, and chimeric antigen receptor T cell (CAR-T) therapies, MCARH109, OriCAR-017, and BMS-986393. In addition to adverse events (AEs) associated with T-cell-redirection therapies irrespective of target, a consistent pattern of dermatologic and oral AEs has been reported across several trials of GPRC5D-targeting bispecific antibodies, as well as rare cerebellar events with CAR-T therapy. Additional studies are needed to understand the underlying mechanisms involved in the development of skin- and oral-related toxicities. We review the strategies that have been used to manage these GPRC5D-related toxicities. Preliminary efficacy data showed overall response rates for GPRC5D-targeting T-cell-redirecting therapies were ≥64%; most responders achieved a very good partial response or better. Pharmacokinetics/pharmacodynamics showed that these therapies led to cytokine release and T-cell activation. In conclusion, results from early phase trials of GPRC5D-targeting T-cell-redirecting agents have shown promising efficacy and manageable safety profiles, including lower infection rates compared with B-cell maturation antigen- and Fc receptor-like protein 5-targeting bispecific antibodies. Further clinical trials, including those investigating GPRC5D-targeting T-cell-redirecting agents in combination with other anti-myeloma therapies and with different treatment modalities, may help to elucidate the future optimal treatment regimen and sequence for patients with multiple myeloma and improve survival outcomes. Video Summary., (© 2024. The Author(s).)

Importance: Bolstering the ranks of women and underrepresented groups in medicine (URM) among medical faculty can help address ongoing health care disparities and therefore constitutes a critical public health need. There are increasing proportions of URM faculty, but comparisons of these changes with shifts in regional populations are lacking., Objective: To quantify the representation of women and URM and assess changes and variability in representation by individual US medical schools., Design, Setting, and Participants: This retrospective cross-sectional study assessed US medical school faculty rosters for women and URM, including American Indian and Alaska Native, Black, Hispanic, and Native Hawaiian or other Pacific Islander faculty. US allopathic medical schools participating in the Association of American Medical Colleges (AAMC) Faculty Administrative Management Online User System from 1990 to 2019 (updated December 31 for each year), were included. Faculty data were analyzed from yearly cross-sections updated as of December 31 for each year from 1990 to 2019. For census data, decennial census data were used for years 1990, 2000, and 2010. Intercensal estimates were used for all other years from 1990 to 2019., Main Outcomes and Measures: Trends and variability in representation quotient (RQ), defined as representation of a group within an institution's faculty compared to its respective US county., Results: There were 121 AAMC member institutions (72 076 faculty) in 1990, which increased to 144 institutions (184 577 faculty) in 2019. The median RQ of women faculty increased from 0.42 (IQR, 0.37-0.46) to 0.80 (IQR, 0.74-0.89) (slope, +1.4% per year; P < .001). The median RQ of Black faculty increased from 0.10 (IQR, 0.06-0.22) to 0.22 (IQR, 0.14-0.41) (slope, +0.5% per year; P < .001), but remained low. In contrast, the median RQ of Hispanic faculty decreased from 0.44 (IQR, 0.19-1.22) to 0.34 (IQR, 0.23-0.62) (slope, -1.7% per year; P < .001) between 1990 and 2019. Absolute total change in RQ of URM showed an increase; however, the 30-year slope did not differ from zero (+0.1% per year; P = .052). Although RQ of women faculty increased for most institutions (127 [88.2%]), large variability in URM faculty trends were observed (57 institutions [39.6%] with increased RQ and 10 institutions [6.9%] with decreased RQ). Nearly one-quarter of institutions shifted from the top to bottom 50th percentile institutional ranking by URM RQ with county vs national comparisons., Conclusions and Relevance: The findings of this cross-sectional study suggest that representation of women in academic medicine improved with time, while URM overall experienced only modest increases with wide variability across institutions. Among URM, the Hispanic population has lost representational ground. County-based population comparisons provide new insights into institutional variation in representation among medical school faculty.

Since its 2015 update, MaizeGDB, the Maize Genetics and Genomics database, has expanded to support the sequenced genomes of many maize inbred lines in addition to the B73 reference genome assembly. Curation and development efforts have targeted high quality datasets and tools to support maize trait analysis, germplasm analysis, genetic studies, and breeding. MaizeGDB hosts a wide range of data including recent support of new data types including genome metadata, RNA-seq, proteomics, synteny, and large-scale diversity. To improve access and visualization of data types several new tools have been implemented to: access large-scale maize diversity data (SNPversity), download and compare gene expression data (qTeller), visualize pedigree data (Pedigree Viewer), link genes with phenotype images (MaizeDIG), and enable flexible user-specified queries to the MaizeGDB database (MaizeMine). MaizeGDB also continues to be the community hub for maize research, coordinating activities and providing technical support to the maize research community. Here we report the changes MaizeGDB has made within the last three years to keep pace with recent software and research advances, as well as the pan-genomic landscape that cheaper and better sequencing technologies have made possible. MaizeGDB is accessible online at https://www.maizegdb.org.